¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"lymphocyte proliferation test2"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
anterior hyaloid fibrovascular proliferation
¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
proliferation
Áõ½Ä
proliferation zone
Áõ½ÄÃþ
pseudoepitheliomatous proliferation
°ÅÁþ»óÇÇÁ¾¼ºÁõ½Ä
pseudosarcomatous proliferation
°ÅÁþÀ°Á¾Áõ½Ä, °¡¼ºÀ°Á¾Áõ½Ä
atypical lymphocyte
ºñÁ¤Çü¸²ÇÁ±¸
effector lymphocyte
È¿°ú¸²ÇÁ±¸
killer lymphocyte
»ìÇØ¸²ÇÁ±¸, ¼¼Æ÷µ¶¼º¸²ÇÁ±¸
lymphocyte
¸²ÇÁ±¸
lymphocyte activating factor
¸²ÇÁ±¸È°¼ºÀÎÀÚ
lymphocyte inhibitory factor
¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
lymphocyte series
¸²ÇÁ±¸°è¿
lymphocyte-activating determinant
¸²ÇÁ±¸È°¼º°áÁ¤ÀÎÀÚ
mixed lymphocyte culture
È¥ÇÕ¸²ÇÁ±¸¹è¾ç
mixed lymphocyte culture test
È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
3
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
proliferation
Áõ½Ä
mixed lymphocyte culture
È¥ÇÕ¸²ÇÁ±¸¹è¾ç
lymphocyte
¸²ÇÁ±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
anterior hyaloid fibrovascular proliferation
¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
proliferation
Áõ½Ä
proliferation zone
Áõ½ÄÃþ
pseudoepitheliomatous proliferation
°ÅÁþ»óÇÇÁ¾¼ºÁõ½Ä
pseudosarcomatous proliferation
°ÅÁþÀ°Á¾¼ºÁõ½Ä, °¡¼ºÀ°Á¾Áõ½Ä
atypical lymphocyte
ºñÀüÇü¸²ÇÁ±¸
lymphocyte-activating determinant
¸²ÇÁ±¸È°¼º°áÁ¤±â
effector lymphocyte
ÀÛµ¿¸²ÇÁ±¸
lymphocyte activating factor
¸²ÇÁ±¸È°¼ºÀÎÀÚ
lymphocyte inhibitory factor
¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
killer lymphocyte
¼¼Æ÷µ¶¼º¸²ÇÁ±¸
lymphocyte
¸²ÇÁ±¸
leukocytoid lymphocyte
¹éÇ÷±¸¸ð¾ç¸²ÇÁ±¸
lymphocyte series
¸²ÇÁ±¸°è¿
primed lymphocyte
ÃÊȸ¹Î°¨¸²ÇÁ±¸
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
T cell ; T lymphocyte ; thymus derived lymphocyte
T¼¼Æ÷ ; T¸²ÇÁ? ; Èä¼±À¯·¡¸²ÇÁ?
anterior hyaloid fibrovascular proliferation
¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
proliferation phase
Áõ½Ä±â(ñòãÖÑ¢).
proliferation zone
Áõ½ÄÃþ
reactive pseudosarcomatous proliferation
¹ÝÀÀ¼º °¡¼ºÀ°Á¾¼º Áõ½Ä(¡Ê£àõë¿ðþàõ)
B cell/lymphocyte
B ¼¼Æ÷/¸²ÇÁ±¸
B lymphocyte
B ¸²ÇÁ±¸
B-lymphocyte
B ¸²ÇÁ±¸.
Bare lymphocyte syndrome
¹«Ç¥Áö¸²ÇÁ±¸ÁõÈıº
T cell/lymphocyte
T ¼¼Æ÷/¸²ÇÁ±¸
T lymphocyte
T ¸²ÇÁ±¸
T-lymphocyte
T-Àӯı¸
anti-lymphocyte globulin
¸²ÇÁ±¸ Çױ۷κҸ°
antigen, lymphocyte defined (LD)
¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
granulocyte-monocyte-lymphocyte antigens
°ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
lymphocyte proliferation
¸²ÇÁ±¸Áõ½Ä
anterior hyaloid fibrovascular proliferation
¾ÕÀ¯¸®Ã¼¼¶À¯Ç÷°üÁõ½Ä
atherosclerosis,intimal smooth muscle proliferation
³»¸·ÆòȰ±Ù Áõ½Ä(ҮدøÁüÀÐÉñòãÖ)
cell proliferation
¼¼Æ÷ Áõ½Ä
cell,proliferation
Áõ½Ä(ñòãÖ)
massive periretinal proliferation<¿¾>=>PVR
Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´Áõ
nuclear proliferation =nucleosis
ÇÙÁõ½Ä(ú·ñòãÖ).
proliferation phase
Áõ½Ä±â(ñòãÖÑ¢).
proliferation zone
Áõ½ÄÃþ
pseudoepitheliomatous proliferation
°¡¼º»óÇÇÁ¾¼º Áõ½Ä
pseudosarcomatous proliferation
°¡¼ºÀ°Á¾¼º Áõ½Ä(Ê£àõë¿ðþàõ ñòãÖ)
reactive pseudosarcomatous proliferation
¹ÝÀÀ¼º °¡¼ºÀ°Á¾¼º Áõ½Ä(¡Ê£àõë¿ðþàõ)
zone of proliferation
Áõ½ÄÃþ, Áõ½Ä´ë (ñòãÖÓá).
anti-lymphocyte globulin
¸²ÇÁ±¸ Çױ۷κҸ°
antigen, lymphocyte defined (LD)
¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½